Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$44.03 USD
-0.08 (-0.18%)
Updated May 17, 2024 03:59 PM ET
After-Market: $44.04 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 261 - 280 ( 438 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY
Provider: Stock Traders Daily
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY
Provider: Stock Traders Daily
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY
Provider: Stock Traders Daily
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Cannabis Market Highlights
Provider: Echelon Welath Partners
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Countdown to EASL Begins: Presentation Titles Released
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y